Peripheral benzodiazepine receptor ligand Ro5-4864 inhibits isoprenaline-induced cardiac hypertrophy in rats

European Journal of Pharmacology

Volumn 644, Issue 1-3, 2010, Pages 146-153

  Jaiswal, Amardeep ^a   Kumar, Santosh ^a   Enjamoori, Rajesh ^a   Seth, Sandeep ^a   Dinda, Amit Kumar ^a   Maulik, Subir Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Echocardiography; Fibrosis; Myocyte size; Myosin heavy chain; Oxidative stress

Indexed keywords

4' CHLORODIAZEPAM; CATALASE; GLUTATHIONE; ISOPRENALINE; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; DRUG MECHANISM; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; LIPID PEROXIDATION; M MODE ECHOCARDIOGRAPHY; MALE; MORPHOMETRICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIOXIDANTS; BENZODIAZEPINONES; CARDIOMEGALY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSIS; ISOPROTERENOL; LIPID PEROXIDATION; MALE; MYOSIN HEAVY CHAINS; OXIDATIVE STRESS; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

EID: 77955770067     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.058     Document Type: Article

References (62)

1. Abraham W.T., Gilbert E.M., Lowes B.D., Minobe W.A., Larrabee P., Roden R.L., Dutcher D., Sederberg J., Lindenfeld J.A., Wolfel E.E., Shakar S.F., Ferguson D., Volkman K., Linseman J.V., Quaife R.A., Robertson A.D., Bristow M.R. Coordinate changes in myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol. Med. 2002, 8:750-760.
2. Aebi H. Catalase. Methods of Enzymatic Analysis 1974, 673-685. Chemic Academic Press Inc., Verlag. H.U. Bergmeyer (Ed.).
3. Ainscough J.F., Drinkhill M.J., Sedo A., Turner N.A., Brooke D.A., Balmforth A.J., Ball S.G. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. Cardiovasc. Res. 2009, 81:592-600.
4. Anholt R.R., Pedersen P.L., De Souza E.B., Snyder S.H. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem. 1986, 261:576-583.
5. Badenhorst D., Veliotes D., Maseko M., Tsotetsi O.J., Brooksbank R., Naidoo A., Woodiwiss A.J., Norton G.R. Beta-adrenergic activation initiates chamber dilatation in concentric hypertrophy. Hypertension 2003, 41:499-504.
6. Benjamin I.J., Jalil J.E., Tan L.B., Cho K., Weber K.T., Clark W.A. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ. Res. 1989, 65:657-670.
7. Boluyt M.O., Long X., Eschenhagen T., Mende U., Schmitz W., Crow M.T., Lakatta E.G. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am. J. Physiol. 1995, 269:H638-H647.
8. Bono F., Lamarche I., Prabonnaud V., Le Fur G., Herbert J.M. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem. Biophys. Res. Commun. 1999, 265:457-461.
9. Boveris A., Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 1973, 134:707-716.
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
11. Carayon P., Portier M., Dussossoy D., Bord A., Petitpretre G., Canat X., Le Fur G., Casellas P. Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood 1996, 87:3170-3178.
12. Chattopadhyay A., Biswas S., Bandyopadhyay D., Sarkar C., Datta A.G. Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine. Mol. Cell. Biochem. 2003, 245:43-49.
13. Cheng T.H., Cheng P.Y., Shih N.L., Chen I.B., Wang D.L., Chen J.J. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J. Am. Coll. Cardiol. 2003, 42:1845-1854.
14. Chess D.J., Xu W., Khairallah R., O'Shea K.M., Kop W.J., Azimzadeh A.M., Stanley W.C. The antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet. Am. J. Physiol. 2008, 295:H2223-H2230.
15. Dhalla A.K., Hill M.F., Singal P.K. Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 1996, 28:506-514.
16. Dhalla N.S., Temsah R.M., Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 2000, 18:655-673.
17. Ellman G.L. Tissue sulphydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
18. Farges R.C., Torres S.R., Ferrara P., Ribeiro-do-Valle R.M. Involvement of steroids in anti-inflammatory effects of peripheral benzodiazepine receptor ligands. Life Sci. 2004, 74:1387-1395.
19. Fariss M.W., Chan C.B., Patel M., Van Houten B., Orrenius S. Role of mitochondria in toxic oxidative stress. Mol. Interv. 2005, 5:94-111.
20. Frey N., Katus H.A., Olson E.N., Hill J.A. Hypertrophy of the heart: a new therapeutic target?. Circulation 2004, 109:1580-1589.
21. Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 1975, 56:56-64.
22. Gupta M.P. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J. Mol. Cell. Cardiol. 2007, 43:388-403.
23. Harada K., Sugaya T., Murakami K., Yazaki Y., Komuro I. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 1999, 100:2093-2099.
24. Harris D.E., Work S.S., Wright R.K., Alpert N.R., Warshaw D.M. Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J. Muscle Res. Cell Motil. 1994, 15:11-19.
25. Holubarsch C., Goulette R.P., Litten R.Z., Martin B.J., Mulieri L.A., Alpert N.R. The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium. Circ. Res. 1985, 56:78-86.
26. Iaccarino G., Dolber P.C., Lefkowitz R.J., Koch W.J. Bbeta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by beta- but not alpha1-adrenergic stimulation. Hypertension 1999, 33:396-401.
27. Jalil J.E., Doering C.W., Janicki J.S., Pick R., Shroff S.G., Weber K.T. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ. Res. 1989, 64:1041-1050.
28. Jones W.K., Grupp I.L., Doetschman T., Grupp G., Osinska H., Hewett T.E., Boivin G., Gulick J., Ng W.A., Robbins J. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J. Clin. Invest. 1996, 98:1906-1907.
29. Joseph-Liauzun E., Delmas P., Shire D., Ferrara P. Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-transmembrane structure. J. Biol. Chem. 1998, 273:2146-2152.
30. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Ind. J. Biochem. Biophys. 1984, 21:130-132.
31. Kannel W.B., Castelli W.P., McNamara P.M., McKee P.A., Feinleib M. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J. Med. 1972, 287:781-787.
32. Kaul N., Siveski-Iliskovic N., Hill M., Slezak J., Singal P.K. Free radicals and the heart. J. Pharmacol. Toxicol. Methods 1993, 30:55-67.
33. Kenyon C.J., Thomson I., Fraser R. Stimulation of aldosterone secretion by benzodiazepines in bovine adrenocortical cells. Fundam. Clin. Pharmacol. 1999, 13:213-219.
34. Kinnally K.W., Zorov D.B., Antonenko Y.N., Snyder S.H., McEnery M.W., Tedeschi H. Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc. Natl. Acad. Sci. 1993, 90:1374-1378.
35. Kinugawa S., Tsutsui H., Hayashidani S., Ide T., Suematsu N., Satoh S., Utsumi H., Takeshita A. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ. Res. 2000, 87:392-398.
36. Krenz M., Sanbe A., Bouyer-Dalloz F., Gulick J., Klevitsky R., Hewett T.E., Osinska H.E., Lorenz J.N., Brosseau C., Federico A., Alpert N.R., Warshaw D.M., Perryman M.B., Helmke S.M., Robbins J. Analysis of myosin heavy chain functionality in the heart. J. Biol. Chem. 2003, 278:17466-17474.
37. Kumar S., Seth S., Jaiswal A., Enjamoori R., Dinda A.K., Ray R., Maulik S.K. Chronic beta-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-alpha and IL-1-beta in rats. Pharmacol. Rep. 2009, 61:870-876.
38. Kumar S., Sood S., Enjamoori R., Jaiswal A., Dinda A.K., Roy T.S., Maulik S.K. Method for enhanced separation of cardiac myosin heavy chain isoforms by non-gradient SDS-PAGE. Anal. Lett. 2009, 2311-2318.
39. Kunduzova O.R., Escourrou G., De La Farge F., Salvayre R., Séguélas M.H., Leducq N., Bono F., Herbert J.M., Parini A. Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion. J. Am. Soc. Nephrol. 2004, 15:2152-2160.
40. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 2005, 18:1440-1463.
41. Leducq N., Bono F., Sulpice T., Vin V., Janiak P., Fur G.L., O'Connor S.E., Herbert J.M. Role of peripheral benzodiazepine receptors in mitochondrial, cellular, and cardiac damage induced by oxidative stress and ischemia-reperfusion. J. Pharmacol. Exp. Ther. 2003, 306:828-837.
42. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 1990, 322:1561-1566.
43. Li J.Y., Wang J.K., Zeng Y.M. Peripheral benzodiazepine receptor agonist Ro5-4864 inhibits mitochondrial permeability transition in rat heart. Sheng Li Xue Bao 2007, 59:13-18.
44. Litwin S.E., Katz S.E., Weinberg E.O., Lorell B.H., Aurigemma G.P., Douglas P.S. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995, 91:2642-2654.
45. Mehta K.D., Garg G.R., Mehta A.K., Arora T., Sharma A.K., Khanna N., Tripathi A.K., Sharma K.K. Reversal of propoxur-induced impairment of memory and oxidative stress by 4'-chlorodiazepam in rats. Naunyn-Schmiedebergs. Arch. Pharmacol. 2010, 381:1-10.
46. Murray D.R., Prabhu S.D., Chandrasekar B. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 2000, 101:2338-2341.
47. Nadal-Ginard B., Mahdavi V. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoforms switches. J. Clin. Invest. 1989, 84:1693-1700.
48. Obame F.N., Zini R., Souktani R., Berdeaux A., Morin D. Peripheral benzodiazepine receptor-induced myocardial protection is mediated by inhibition of mitochondrial membrane permeabilization. J. Pharmacol. Exp. Ther. 2007, 323:336-345.
49. Okhawa H., Oohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
50. Pick R., Jalil J.E., Janicki J.S., Weber K.T. The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Am. J. Pathol. 1989, 134:365-371.
51. Reddy D.S., Kulkarni S.K. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice. Methods Find. Exp. Clin. Pharmacol. 1997, 19:665-681.
52. Sawyer D.B., Siwik D.A., Xiao L., Pimentel D.R., Singh K., Colucci W.S. Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 2002, 34:379-388.
53. Singal P.K., Dhalla A.K., Hill M., Thomas T.P. Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions. Mol. Cell. Biochem. 1993, 129:179-186.
54. Siwik D.A., Tzortzis J.D., Pimental D.R., Chang D.L., Pagano P.J., Singh K., Sawyer D.B., Colucci W.S. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ. Res. 1999, 85:147-153.
55. Sugiura S., Kobayakawa N., Fujita H., Yamashita H., Momomura S., Chaen S., Omata M., Sugi H. Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation. Circ. Res. 1998, 82:1029-1034.
56. Takimoto E., Kass D.A. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007, 49:241-248.
57. Torres S.R., Fröde T.S., Nardi G.M., Vita N., Reeb R., Ferrara P., Ribeiro-do-Valle R.M., Farges R.C. Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur. J. Pharmacol. 2000, 408:199-211.
58. Tsutsui H., Kinugawa S., Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc. Res. 2009, 81:449-456.
59. Weber K.T., Brilla C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991, 83:1849-1865.
60. Woodiwiss A.J., Tsotetsi O.J., Sprott S., Lancaster E.J., Mela T., Chung E.S., Meyer T.E., Norton G.R. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 2001, 103:155-160.
61. Zhang G.X., Kimura S., Nishiyama A., Shokoji T., Rahman M., Yao L., Nagai Y., Fujisawa Y., Miyatake A., Abe Y. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc. Res. 2005, 65:230-238.
62. Zhang G.X., Ohmori K., Nagai Y., Fujisawa Y., Nishiyama A., Abe Y., Kimura S. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice. J. Mol. Cell. Cardiol. 2007, 42:804-811.